Dale Q Rice Investment Management Ltd Makes New $780,000 Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Dale Q Rice Investment Management Ltd purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, Holdings Channel.com reports. The firm purchased 5,899 shares of the financial services provider’s stock, valued at approximately $780,000.

Several other institutional investors have also recently made changes to their positions in the company. PVG Asset Management Corp bought a new stake in iShares Biotechnology ETF during the second quarter valued at $415,000. Huntington National Bank boosted its position in shares of iShares Biotechnology ETF by 17.9% during the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after acquiring an additional 160 shares during the last quarter. National Bank of Canada FI grew its holdings in shares of iShares Biotechnology ETF by 5.9% during the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after purchasing an additional 229 shares in the last quarter. First Financial Bank Trust Division bought a new position in shares of iShares Biotechnology ETF in the third quarter worth approximately $204,000. Finally, Thrive Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the third quarter valued at approximately $445,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.0 %

Shares of iShares Biotechnology ETF stock opened at $134.02 on Tuesday. The company has a 50 day simple moving average of $137.95 and a two-hundred day simple moving average of $141.99. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.